These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 6328268)

  • 1. N-terminal amino acid sequences of the polyoma middle-size T antigen are important for protein kinase activity and cell transformation.
    Templeton D; Eckhart W
    Mol Cell Biol; 1984 May; 4(5):817-21. PubMed ID: 6328268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of viable mutants of polyomavirus cold sensitive for maintenance of cell transformation.
    Templeton D; Eckhart W
    J Virol; 1984 Mar; 49(3):799-805. PubMed ID: 6321764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormonal regulation of a polyoma virus middle-size T-antigen gene linked to growth hormone control sequences.
    Heiser WC; Eckhart W
    J Gen Virol; 1985 Oct; 66 ( Pt 10)():2147-60. PubMed ID: 2995552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the polyoma-virus-induced tumor-specific transplantation antigen (TSTA)--does middle or large T-antigen play a role?
    Dalianis T; Ramqvist T; Klein G
    Int J Cancer; 1984 Sep; 34(3):403-6. PubMed ID: 6090322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic and biochemical analysis of transformation-competent, replication-defective simian virus 40 large T antigen mutants.
    Manos MM; Gluzman Y
    J Virol; 1985 Jan; 53(1):120-7. PubMed ID: 2981330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activities of polyomavirus large-T-antigen proteins expressed by mutant genes.
    Nilsson SV; Magnusson G
    J Virol; 1984 Sep; 51(3):768-75. PubMed ID: 6088799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming activity of polyoma virus middle-T antigen probed by site-directed mutagenesis.
    Oostra BA; Harvey R; Ely BK; Markham AF; Smith AE
    Nature; 1983 Aug 4-10; 304(5925):456-9. PubMed ID: 6308461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The major site of tyrosine phosphorylation in polyomavirus middle T antigen is not required for transformation.
    Mes-Masson AM; Schaffhausen B; Hassell JA
    J Virol; 1984 Nov; 52(2):457-64. PubMed ID: 6092671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transmission of the polyoma virus middle T gene as the oncogene of a murine retrovirus.
    Donoghue DJ; Anderson C; Hunter T; Kaplan PL
    Nature; 1984 Apr 19-25; 308(5961):748-50. PubMed ID: 6325917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Less than 40% of the simian virus 40 large T-antigen-coding sequence is required for transformation.
    Sompayrac L; Danna KJ
    Mol Cell Biol; 1984 Aug; 4(8):1661-3. PubMed ID: 6092929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations around the NG59 lesion indicate an active association of polyoma virus middle-T antigen with pp60c-src is required for cell transformation.
    Cheng SH; Markland W; Markham AF; Smith AE
    EMBO J; 1986 Feb; 5(2):325-34. PubMed ID: 3011402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transformation by polyoma virus is drastically reduced by substitution of phenylalanine for tyrosine at residue 315 of middle-sized tumor antigen.
    Carmichael G; Schaffhausen BS; Mandel G; Liang TJ; Benjamin TL
    Proc Natl Acad Sci U S A; 1984 Feb; 81(3):679-83. PubMed ID: 6322163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The amino terminus of polyomavirus middle T antigen is required for transformation.
    Cook DN; Hassell JA
    J Virol; 1990 May; 64(5):1879-87. PubMed ID: 2157858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simian virus 40 large T-antigen point mutants that are defective in viral DNA replication but competent in oncogenic transformation.
    Manos MM; Gluzman Y
    Mol Cell Biol; 1984 Jun; 4(6):1125-33. PubMed ID: 6330530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transformation of rat fibroblasts by cloned defective polyoma DNA.
    Parent C; Bastin M
    Arch Int Physiol Biochim; 1981 Sep; 89(3):225-33. PubMed ID: 6171226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A viable mouse polyomavirus mutant without immortalizing or transforming activities.
    Linder S; Nilsson M; Martens I; Magnusson G
    Virology; 1990 Nov; 179(1):78-86. PubMed ID: 2171224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of the origin-specific DNA-binding domain of polyomavirus large T antigen.
    Sunstrom NA; Acheson NH; Hassell JA
    J Virol; 1991 Dec; 65(12):6998-7003. PubMed ID: 1658390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation causing premature termination of the polyoma virus medium T antigen blocks cell transformation.
    Templeton D; Eckhart W
    J Virol; 1982 Mar; 41(3):1014-24. PubMed ID: 6284958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletions of N-terminal sequences of polyoma virus T-antigens reduce but do not abolish transformation of rat fibroblasts.
    Katinka M; Yaniv M
    Mol Cell Biol; 1982 Oct; 2(10):1238-46. PubMed ID: 6294500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The nucleotide binding site detected by affinity labeling in the large T proteins of polyoma and SV40 viruses is distinct from their ATPase catalytic site.
    Clertant P; Gaudray P; May E; Cuzin F
    J Biol Chem; 1984 Dec; 259(24):15196-203. PubMed ID: 6096361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.